Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-24

Clinical Trial Update: Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing adapalene gel 0.3% to tretinoin 0.05% emollient cream for photodamage (photoaging) completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene Gel 0.3% (adapalene)
  • tretinoin 0.05% emollient cream (tretinoin)

Snippet

Sponsor: Galderma R&D | Conditions: Photoaging | Phase 3 | Status: COMPLETED | Results posted: 2011-02-24